A public health/health economics consultancy (CEMKA, France) assisted with the organisation and delivery of the consensus process.
Disclosures
Julie Le Mao, Lauriane Villemur and Stephane Bouée are employees of CEMKA. Jerome De Sèze has received fees for consultancy, advisory board and clinical trials from UCB, Novartis, Biogen, Merck, Teva, Genzyme/ Sanofi, Roche, Alexion, BMS/Celegene, Janssen, Horizon Therapeutics. Patrick Vermersch reported honoraria, contributions to meeting from Biogen, Sanofi-Genzyme, Novartis, Teva, Merck, Roche, Imcyse, AB Science, Almirall and BMS-Celgene, and research support from Novartis, Sanofi-Genzyme and Roche. Bertrand Bourre serves on scientific advisory boards and has received funding for travel and honoraria rom Alexion, Biogen, BMS, Merck, Novartis, Sanofi, Roche and Teva. Bertrand Bourre’s institution received research support in his department from Merck Serono, Biogen, Novartis and Genzyme. Abdullatif Al Khedr received honoraria for contributions to meetings from Biogen, Sanofi-Genzyme, Novartis, Merck and Roche. Gilles Defer has received personal compensation for scientific advisory boards for Biogen, Novartis, BMS, Genzyme, Merck Serono, Roche and Teva and has received speaker honoraria and travel grants from Merck Serono, Biogen, Novartis, BMS, Roche, Genzyme and Teva. Pierre Labauge received honoraria for contributions to meeting from Biogen, Sanofi-Genzyme, Novartis, Teva, Merck, Roche, Almirall and BMS-Celgene, and research support from Novartis, Sanofi-Genzyme and Roche. Laurent Suchet received honoraria, contributions to meetings/boards from Biogen, Sanofi-Genzyme, Novartis, Teva, Merck, Roche, and BMS-Celgene, research support from Sanofi-Genzyme and Roche. Claude Mekies serves on scientific advisory boards for Novartis, Téva, Biogen, Roche, Sanofi, Genzyme, Bayer, Merck, Lilly, Eisai, and received funding for travel and honoraria from Novartis, Téva, Biogen, Roche, Sanofi, Merck, Genzyme, Bayer, BMS, Pfizer, Lilly, GSK. Anne-Marie Guennoc reported receiving personal fees from Biogen, Merk, Novartis, Sanofi and Roche outside the submitted work. Giovanni Castelnovo received fees for consulting and speaking from Biogene, Abbvie, Merck, Novartis, Roche, Sanofi Genzyme, Merz, Celgene BMS. Caroline Bensa-Koscher received fees for consulting or scientific advisory board for Biogen, Merck Serono, Novartis, Sanofi, Teva, Alexion, BMS, and for clinical trials (phase 2 or phase 3) as principal investigator or investigator for Biogen, Roche, Sanofi. Pierre Clavelou has received honoraria, and contributions to meeting from Almirall, Biogen, Janssen, Merck, Novartis, Roche, Sanofi-Genzyme, Teva. Eric Manchon has received fees for consultancy and clinical trials for Roche, Biogen, Novartis, Sanofi, Merck. Laura Luciani is a full-time employee of Merck Santé, Lyon, France, an affiliate of Merck KGaA, Darmstadt, Germany.